These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 26146916

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE, Lake JD.
    Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
    [No Abstract] [Full Text] [Related]

  • 27. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ, Reichman ME, Wernecke M, Zhang R, Southworth MR, Levenson M, Sheu TC, Mott K, Goulding MR, Houstoun M, MaCurdy TE, Worrall C, Kelman JA.
    Circulation; 2015 Jan 13; 131(2):157-64. PubMed ID: 25359164
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
    Ho CW, Ho MH, Chan PH, Hai JJ, Cheung E, Yeung CY, Lau KK, Chan KH, Lau CP, Lip GY, Leung GK, Tse HF, Siu CW.
    Stroke; 2015 Jan 13; 46(1):23-30. PubMed ID: 25406148
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Response to letter regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
    Chan PH, Hai JJ, Siu CW.
    Stroke; 2015 Mar 13; 46(3):e72. PubMed ID: 25649808
    [No Abstract] [Full Text] [Related]

  • 37. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R, Salhanick SD, Chase M, Ganetsky M.
    Ann Emerg Med; 2013 Apr 13; 61(4):475-9. PubMed ID: 23522810
    [Abstract] [Full Text] [Related]

  • 38. Diffuse alveolar hemorrhage associated with dabigatran.
    Yokoi K, Isoda K, Kimura T, Adachi T.
    Intern Med; 2012 Apr 13; 51(18):2667-8. PubMed ID: 22989848
    [No Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
    Shah SV, Gage BF.
    Circulation; 2011 Jun 07; 123(22):2562-70. PubMed ID: 21606397
    [Abstract] [Full Text] [Related]

  • 40. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
    Koziński M, Obońska K, Kubica A, Navarese EP, Kubica J.
    Kardiol Pol; 2012 Jun 07; 70(10):1053-60. PubMed ID: 23080100
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.